Analysis of Tryptophan Metabolic Profile Characteristics and Clinical Value in Differentiated Thyroid Cancer Patients
Cancer Medicine · 2025
DOI: 10.1002/cam4.70808 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Qiang Miao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Tryptophan, Thyroid Neoplasms, Biomarkers, Tumor, Metabolome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Differentiated thyroid cancer (DTC) is the primary subtype of thyroid cancer. Timely diagnosis and intervention are crucial for improving prognosis and survival. However, the effectiveness of existing serum markers is limited, necessitating the discovery of new biomarkers.
Methods
This study utilized liquid chromatography–tandem mass spectrometry to analyze tryptophan metabolic profiles in serum samples from 105 DTC patients and 50 healthy controls. Independent predictors of DTC were identified through univariate intergroup comparisons and multivariate logistic regression analysis, leading to the development and validation of a new diagnostic model.
Results
Significant differences were observed in 11 tryptophan metabolites between DTC patients and controls. Logistic regression identified nicotinamide, 3‐hydroxyanthranilic acid, 5‐hydroxytryptophan, melatonin, and indole‐3‐propionic acid as independent predictors. The nomogram prediction model was established based on these five metabolites, and according to the Hosmer–Lemeshow test, the model showed good fit. The five‐metabolite diagnostic model demonstrated 84.8% sensitivity, 90.0% specificity, and an area under the ROC curve of 0.932. Decision curve analysis indicated that the model had significant advantages over serum thyroglobulin.
Discussion
Tryptophan metabolism exhibits distinct changes in DTC patients, with specific metabolites serving as early diagnostic markers. The five‐metabolite panel demonstrates potential for improving early detection and management of DTC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Sichuan Clinical Research Center for Laboratory Medicine, Chengdu, Sichuan, China.
- Clinical Laboratory Medicine Research Center, of West China Hospital, Chengdu, Sichuan, China.
- Division of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
ORCID-Profile: Junlong Zhang, Han Luo, Bei Cai
Zitieren
APA
Miao, Q., Dai, X., Wu, X., Luo, L., Zhang, J., Luo, H., & Cai, B. (2025). Analysis of Tryptophan Metabolic Profile Characteristics and Clinical Value in Differentiated Thyroid Cancer Patients. Cancer Medicine. https://doi.org/10.1002/cam4.70808
Vancouver
Miao Q, Dai X, Wu X, Luo L, Zhang J, Luo H, et al. Analysis of Tryptophan Metabolic Profile Characteristics and Clinical Value in Differentiated Thyroid Cancer Patients. Cancer Medicine. 2025. doi:10.1002/cam4.70808
BibTeX
@article{Miao2025,
author = {Miao, Qiang and Dai, Xinhua and Wu, Xiaojuan and Luo, Li and Zhang, Junlong and Luo, Han and Cai, Bei},
title = {Analysis of Tryptophan Metabolic Profile Characteristics and Clinical Value in Differentiated Thyroid Cancer Patients},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70808}
}
EUVIMED